Bone Metastasis Experimental and Clinical Therapeutics /
Bone metastasis occurs in 60 to 85% of all breast, prostate, and lung cancer patients and is responsible for increasing morbidity. In Bone Metastasis: Experimental and Clinical Therapeutics, leading bone metastasis experts from around the world explain the molecular underpinnings of the process, rev...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press,
2005.
|
| Series: | Cancer Drug Discovery and Development
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Fundamental Concepts
- Overview
- Parathyroid Hormone-Related Peptide and Malignancy
- Vitamin D and Vitamin D Analogs in Cancer Progression and Metastasis
- Role of TGF-? and IGF in Tumor Progression and Bone Metastases
- Biologic and Therapeutic Implications of Osteomimicry and Epithelial-Mesenchymal Transition in Prostate Cancer
- Roles of Immune-Cell-Derived Matrix Metalloproteinases in Tumor Growth and Metastasis
- Contribution of Osteopontin to the Development of Bone Metastasis
- Role of Interleukin-11 in Osteolytic Bone Metastasis
- Cell Adhesion Molecules in Tumor Metastasis
- PTHrP and Cancer
- Antithrombotics in Tumor Growth and Metastasis
- Therapeutic Strategies
- Challenges and Strategies in the Analysis of Multiple Events in Oncology
- Integrins
- Bone Metastasis and Pathological Fractures
- Role of Photodynamic Therapy for Bone Metastasis
- Docetaxel for Metastatic Cancer and Its Role in Combination Therapies for Advanced Prostate Cancer
- Use of Tetracyclines for Bone Metastases
- Role of Bisphosphonates in Skeletal Metastases
- Radiation Treatment of Bone Metastases.
